4[2]Hanifin JM,Rajka G.Diagnostic criteria of dermatitis[J].Acta Derm Venereol,1980,(Suppl):44.
5[5]Stadler Beda M, Miescher Sylvia, Horn Michael, et al. Allergic manifestations as the results of a conditional autoimmune response[J].Int Arch Allergy Immunol,2001,124:411-413.
6[6]Sommer S, Wilkinson SM, Beck MH, et al. Type Ⅳ hypersensitivity reactions to natural rubber latex:results of a multicentre study[J]. Br J Dermatol, 202,146:114-117.
7赵辩.寻常痤疮.临床皮肤病学（第3版）[M].南京:江苏科学技术出版社,2001.935.
8Lin X,Wilkinson DI,Huang T,et al.Experimental studies on topoisomerase inhibitor camptothecin as an antipsoriatic agent[J].Chin Med J (Engl),1999,112:504-508.
3Farley E, Masrour S, McKey J, etal. Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool[J]. J Am Acad Dermatol,2009,60 (6) : 1024-1031.
4Reitamo S, Erkko P, Remitz A. Cyclosporin for palmoplantar pustulosis[J]. J Autoimmun,1992,5(Suppl A) :285-287.
5Marsland A M, Griffiths C E. Treatments for chronic palmoplantar pustular psoriasis[J]. Skin Therapy Lett, 2001,6 (12) :3-5.
6MacDonald A, Burden A D. Psoriasis: advance in pathophysiology and management [ J ]. Postgrad Med J, 2007, 83 (985): 690.
7张学军.临床皮肤病学[M].第五版.北京:人民卫生出版社,2001:117-118.
8Torii H, Sato N, Yoshinari T, et al. Dramatic impact of a Psoriasis Area and Severity Index 90 response on the quality of life in patients with psoriasis: An analysis of Japanese clinical trials of infliximab[J]. J Dermatol, 2012,39(3):253-259.
9Eyerich S, Onken A T, Weidinger S, et al. Mutual antagonism of T cells causing psoriasis and atopie eczema[J]. N Engl ./Med, 2011,365 (3):231-238.
10Carrier Y, Ma bI L, Ramon H E, et al. Inter-regulation of Thl7 cy- tokines and the ID36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis[J]. J Invest Dermatol, 2011,131 ( 12):2428-2437.
